| Dr Bradley A Serwer, MD | |
|
8901 Wisconsin Avenue, Bethesda, MD 20889-0001 | |
| (301) 295-0390 | |
| Not Available |
| Full Name | Dr Bradley A Serwer |
|---|---|
| Gender | Male |
| Speciality | Interventional Cardiology |
| Experience | 23 Years |
| Location | 8901 Wisconsin Avenue, Bethesda, Maryland |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013978311 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Wayne Memorial Hospital | Honesdale, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Wayne Memorial Hospital | 4082522149 | 11 |
News Archive
CEVEC Pharmaceuticals, the developer of a novel human expression system derived from amniocytes, and Aragen Bioscience, Inc., a California based contract research and development organization, announced today the signing of a strategic license agreement. This license enables Aragen Bioscience to offer its clients custom recombinant human cell lines expressing biotherapeutic proteins and antibodies as well as the transient and stable production of preclinical and clinical grade material.
Amsterdam Molecular Therapeutics, a leader in the field of human gene therapy, announced today that it has successfully treated Duchenne muscular dystrophy (DMD) in an animal model with its proprietary gene therapy. The proof of concept studies were performed in collaboration with the group of Professor Irene Bozzoni (University of Rome, La Sapienza, Italy) and demonstrated effectiveness in the heart as well as in skeletal muscles.
Genentech, Inc., a wholly owned member of the Roche Group, today announced results from a Phase III study of Avastin (bevacizumab) that showed women with previously untreated advanced ovarian cancer who received Avastin in combination with chemotherapy, followed by the continuation of Avastin alone, had a 39 percent improvement in the likelihood of living longer without the disease worsening (progression-free survival or PFS) compared to chemotherapy alone.
Health Dialog, a leading provider of integrated population health management solutions for health plans, risk-bearing providers and self-insured employers, will release data showing its telephonic health coaching program helped patients managing diabetes, hypertension and high cholesterol achieve a higher rate of adherence than patients without coaching.
Usher syndrome is a hereditary disease in which affected individuals lose both hearing and vision. The impact of Usher syndrome can be devastating. In the United States, approximately six in every 100,000 babies born have Usher syndrome.
› Verified 3 days ago
| Entity Name | Wayne Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124026182 PECOS PAC ID: 4082522149 Enrollment ID: O20040707001239 |
News Archive
CEVEC Pharmaceuticals, the developer of a novel human expression system derived from amniocytes, and Aragen Bioscience, Inc., a California based contract research and development organization, announced today the signing of a strategic license agreement. This license enables Aragen Bioscience to offer its clients custom recombinant human cell lines expressing biotherapeutic proteins and antibodies as well as the transient and stable production of preclinical and clinical grade material.
Amsterdam Molecular Therapeutics, a leader in the field of human gene therapy, announced today that it has successfully treated Duchenne muscular dystrophy (DMD) in an animal model with its proprietary gene therapy. The proof of concept studies were performed in collaboration with the group of Professor Irene Bozzoni (University of Rome, La Sapienza, Italy) and demonstrated effectiveness in the heart as well as in skeletal muscles.
Genentech, Inc., a wholly owned member of the Roche Group, today announced results from a Phase III study of Avastin (bevacizumab) that showed women with previously untreated advanced ovarian cancer who received Avastin in combination with chemotherapy, followed by the continuation of Avastin alone, had a 39 percent improvement in the likelihood of living longer without the disease worsening (progression-free survival or PFS) compared to chemotherapy alone.
Health Dialog, a leading provider of integrated population health management solutions for health plans, risk-bearing providers and self-insured employers, will release data showing its telephonic health coaching program helped patients managing diabetes, hypertension and high cholesterol achieve a higher rate of adherence than patients without coaching.
Usher syndrome is a hereditary disease in which affected individuals lose both hearing and vision. The impact of Usher syndrome can be devastating. In the United States, approximately six in every 100,000 babies born have Usher syndrome.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Bradley A Serwer, MD 5308 Locust Ave, Bethesda, MD 20814-1607 Ph: (240) 328-2073 | Dr Bradley A Serwer, MD 8901 Wisconsin Avenue, Bethesda, MD 20889-0001 Ph: (301) 295-0390 |
News Archive
CEVEC Pharmaceuticals, the developer of a novel human expression system derived from amniocytes, and Aragen Bioscience, Inc., a California based contract research and development organization, announced today the signing of a strategic license agreement. This license enables Aragen Bioscience to offer its clients custom recombinant human cell lines expressing biotherapeutic proteins and antibodies as well as the transient and stable production of preclinical and clinical grade material.
Amsterdam Molecular Therapeutics, a leader in the field of human gene therapy, announced today that it has successfully treated Duchenne muscular dystrophy (DMD) in an animal model with its proprietary gene therapy. The proof of concept studies were performed in collaboration with the group of Professor Irene Bozzoni (University of Rome, La Sapienza, Italy) and demonstrated effectiveness in the heart as well as in skeletal muscles.
Genentech, Inc., a wholly owned member of the Roche Group, today announced results from a Phase III study of Avastin (bevacizumab) that showed women with previously untreated advanced ovarian cancer who received Avastin in combination with chemotherapy, followed by the continuation of Avastin alone, had a 39 percent improvement in the likelihood of living longer without the disease worsening (progression-free survival or PFS) compared to chemotherapy alone.
Health Dialog, a leading provider of integrated population health management solutions for health plans, risk-bearing providers and self-insured employers, will release data showing its telephonic health coaching program helped patients managing diabetes, hypertension and high cholesterol achieve a higher rate of adherence than patients without coaching.
Usher syndrome is a hereditary disease in which affected individuals lose both hearing and vision. The impact of Usher syndrome can be devastating. In the United States, approximately six in every 100,000 babies born have Usher syndrome.
› Verified 3 days ago
Ardalan Enkeshafi, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 6410 Rockledge Dr Ste 304, Bethesda, MD 20817 Phone: 443-602-6207 | |
Dr. Tara Palmore, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 10 Center Dr, Msc 1888, Bethesda, MD 20892 Phone: 301-496-4000 | |
Dr. Cornelia Diana Cudrici, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 10 Center Drive Bld 10 Rm 6n216a, Bethesda, MD 20892 Phone: 301-443-5519 | |
Shanthi Murgesh Nadar, Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 8600 Old Georgetown Road, Bethesda, MD 20814 Phone: 301-896-3100 | |
Dr. Nicole Jeanine Gormley, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 10 Center Dr, Bldg 10, Rm 2c145, Bethesda, MD 20892 Phone: 301-496-9320 | |
Dr. Harshkumar Patel, MBBS Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 10 Center Dr, Bethesda, MD 20892 Phone: 301-496-9320 Fax: 301-402-1213 | |
Dr. Tung N Dao, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 6410 Rockledge Dr, Ste 200, Bethesda, MD 20817 Phone: 301-897-5301 Fax: 301-564-4289 |